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ABSTRACT 
 
Allergies have increased strikingly in the affluent parts of the world during the last century. The cause of the 
rapid increase is unknown but several risk factors have been postulated, the main ones relating to reduced 
microbial exposures and changed diet. In parallel with the increased prevalence of allergies, consumption of 
saturated fat has declined, while consumption of polyunsaturated fat has risen. The change in dietary fatty acid 
composition is suggested to influence the risk of developing allergy. 
 
This thesis work aimed to investigate whether and how the fatty acid compositions in the body and in the diet 
affect allergy development. The fatty acid pattern in breast milk and serum was investigated in women with 
different allergic manifestations. Furthermore, the fatty acid pattern in cord blood was analyzed as a putative 
factor affecting subsequent development of allergies. In animal models, the effect of diets rich in polyunsaturated 
fatty acids (PUFAs) on different types of immune responses and hypersensitivity reactions was studied and the 
consumption of PUFAs during allergic reactions was evaluated. Since dairy farms are known to be an allergy-
preventing environment, dietary differences between farmers and non-farmers were investigated. 
 
Lactating women with an allergic phenotype that included eczema had PUFA patterns in breast milk and serum 
that differed from that of non-allergic women and women with respiratory allergies. Eczematous women had 
lower levels of several PUFAs, such as arachidonic acid (AA), eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), compared to non-allergic women as well as women with isolated respiratory 
allergy. Fatty acid pattern in cord blood was measured in children that subsequently developed eczema or 
respiratory allergies. Infants who later developed allergies had higher cord blood levels of PUFAs, both from the 
n-3 and n-6 series, than children who stayed non-allergic. Studies in mouse models showed that a diet rich in n-3 
PUFA (supplemented with fish oil) increased IgE production in an airway hypersensitivity model, but 
suppressed proliferation and cytokine production of T cells in a delayed-type hypersensitivity (DTH) model. 
During the challenge phase and the resulting allergic inflammatory reaction a significant reduction of PUFAs 
was monitored in both models, but most obvious in the airway model. When comparing farming and non-
farming women, farmers had higher levels of saturated fatty acids (SAFAs) and lower levels of PUFAs in their 
breast milk. Farmers also had a higher intake of foods containing SAFAs, such as butter and whole-fat dairy 
products. Conversely, non-farmers had a higher intake of PUFA-rich margarine and low-fat dairy products.  
 
In conclusion, fatty acid pattern in the body and fatty acid composition in the diet are associated with allergy 
development. Dietary intake of both n-3 and n-6 PUFAs appear to facilitate atopic sensitization and allergy 
development in both a prospective birth-cohort study and in an experimental allergy model. The PUFAs are then 
consumed in the body during the allergic inflammatory reaction, which may explain the low PUFA levels 
characterizing allergic subjects. Thus, high intake of PUFAs may predispose to allergy and a diet rich in 
saturated fatty acids and low in PUFAs may be one factor explaining the low allergy prevalence among children 
growing up on dairy farms. 
 
Keywords: fatty acids, polyunsaturated fatty acids, saturated fat, butter, margarine, fish oil, breast milk, serum, 
cord blood, farming, allergy, atopy, IgE, DTH  
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PLS  partial least square 
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PMN  polymorphonuclear neutrophils 
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PUFA polyunsaturated fatty acids 
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TAG  triacylglycerol 
TGF-β  transforming growth factor β 
TNF  tumor necrosis factor 
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INTRODUCTION 
Allergy denotes immunologically mediated hypersensitivity. In allergy, a harmless 
foreign substance elicits an immune response (sensitization), and renewed encounter of 
the antigen elicits inflammation that causes symptoms (hypersensitivity). Allergies may 
result from different types of immune reactions. IgE-mediated reactions cause atopic 
allergies while CD4+ T cells cause delayed-type hypersensitivity (DTH) reactions termed 
contact allergy. 
 
The prevalence of IgE-mediated allergies has increased enormously in the affluent parts 
of the world during the last century. In Sweden about 25% of the population suffers from 
asthma, hay fever or atopic eczema, and 15-20% have contact allergy [1]. This makes 
allergy one of the most widespread diseases and national economic costs. In Sweden it 
has been estimated at about 10 billion SEK per year [2]. Although genetic factors play a 
role, they cannot explain the rapid increase in allergies, i.e. a tripling of the incidence 
between 1970 and 1990 in Sweden and other Western countries. Several risk and 
protective factors have been postulated, the main ones relating to reduced microbial 
exposures and changed diet. 
 
The hygiene hypothesis was put forward by Strachan in 1989 [3]. He proposed that early 
childhood infections were required to induce proper maturation of the immune system. 
Another factor proposed to underlie, or contribute to, increased allergy prevalence is 
changes in dietary habits. Black and Sharpe [4] suggested that a decreased intake of 
saturated fat and increased intake of polyunsaturated fat may be associated with the 
parallel increase in allergy prevalence. There is also evidence of reduced incidence of 
atopic eczema in children whose diet has included fish [5-7]. The farming environment 
has long been known to be protective against allergies [8-19]. Early and regular contact 
with livestock appears to be a strong protective factor [9, 12, 17], but differences in 
dietary habits might also play an important role. 
 
This thesis, and the papers on which the thesis is based, investigates the role of dietary 
factors and fatty acid patterns in serum and breast milk in allergy development. Dietary 
habits that could be protective factors in farming families are studied in an 
epidemiological study. Associations between fatty acid profiles in serum and breast milk 
and different allergic manifestations, both in lactating women and children, are 
investigated. In addition, studies in animal models have been used to survey how diets 
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rich in n-3 and n-6 polyunsaturated fatty acids (PUFAs) affect different hypersensitivity 
reactions. 
 
The project was conducted as collaboration between the Department of Chemical and 
Biological Engineering/Food Science at Chalmers University of Technology and the 
Department of Infectious Medicine/Clinical Bacteriology at the University of 
Gothenburg. The Farm Flora study is collaboration which also includes the Department of 
Public Health and Community Medicine/Public Health Epidemiology Unit, Institute of 
Medicine/Rheumatology and Inflammation Research and Department of Clinical Science/ 
Pediatrics at the University of Gothenburg, and Västra Götaland regional Health Care. 
The prospective birth cohort study was done in collaboration with the Department of 
Pediatrics at Umeå University and the Department of Pediatrics at Östersund Hospital. 
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OBJECTIVES 
The overall aim of this thesis was to investigate whether fatty acid pattern in the body and 
fatty acid composition in the diet are associated with allergy development, with a focus 
on polyunsaturated fatty acids (PUFAs). 
 
Specific aims were: 
 
• To investigate whether and how diets rich in PUFAs (both n-3 and n-6) affect 
allergy development in humans and animal models. 
 
• To survey whether PUFA pattern in umbilical cord blood relates to risk of later 
development of allergies. 
 
• To investigate whether PUFAs are consumed in the body during sensitization 
and allergic reactions in animal models. 
 
• To study whether the PUFA pattern in breast milk and serum could be related 
to allergic disease, and to evaluate whether different allergic manifestations 
give raise to different PUFA profiles. 
 
• To evaluate whether there are differences in dietary habits between farming and 
non-farming women, to investigate whether dietary intake of fatty acids is 
reflected in their breast milk and to study whether possible differences in 
dietary habits could be related to protection against allergy development. 
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BACKGROUND 
John Bostock [20] first described hay fever in 1819 and noted that poor people and 
farmers seldom suffered from this disease, which seemed to affect only wealthy people. 
Since then, the prevalence of allergies has increased dramatically [21]. Although the 
cause of allergy is unknown, a few hypotheses have been proposed. Most of them are 
based on factors associated with Western lifestyle. 
In 1989 David Strachan postulated the hygiene hypothesis [3] to explain the inverse 
relationship between poverty and family size and risk of allergy development. He 
proposed that infections in early childhood, transmitted via contacts with elder siblings, 
reduced the risk of allergic disease. The hygiene hypothesis is supported by several other 
correlations between lifestyle and allergy. Examples of such protective factors are 
attendance of day-care at an early age [22, 23], exposure to pets [24-26], poverty and 
crowded housing conditions [27]. All of these factors are associated with high exposure to 
microorganisms. 
Several studies have demonstrated that growing up on a farm with livestock lends 
powerful protection against allergy development [9-11, 13-16]. The protective 
mechanisms are still to be elucidated, but two hypotheses are: 1. exposure to protective 
microorganisms through contact with animals and through the diet, and 2. dietary factors 
that modulate the immune system in a protective way.  
Epidemiological and experimental evidence suggests that dietary habits may influence the 
risk of developing allergy. Black and Sharpe [4] proposed that changed patterns of fatty 
acid intake in the West have contributed to the rise in allergies. Parallel to the increased 
prevalence of allergies, consumption of saturated fat has declined and consumption of 
PUFAs, essentially from the n-6 series, has risen [28, 29].  
Lipids 
Lipids are a broad group of naturally occurring molecules whose main biological 
functions include energy storage, formation of cell membranes and action as signaling 
molecules. Lipids are usually divided into eight categories; fatty acyls, glycerolipids, 
glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids and 
polykerides [30]. These categories can be further subdivided; in this thesis, only fatty 
acids, eicosanoids (both belonging to the fatty acyl group), triacylglycerols (glycerolipid 
group) and phospholipids (glycerophospholipids) will be further treated, with the greatest 
emphasis on fatty acids. 
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Fatty acids are the simplest lipids and are used as building blocks in triacylglycerols and 
phospholipids, Fig 1. Triacylglycerols are esters derived from glycerol and three fatty 
acids. Triacylglycerols are the major storage form of fat in the body. Phospholipids are 
key components in lipids bilayer of cell membranes. They consist of a diglyceride, i.e. a 
glycerol molecule and two fatty acids at position 1 and 2. The third OH-group, at position 
3, is connected to a phosphate group which in turn is linked to cholin, serine or 
ethanolamine. 
 
 
Fig. 1 A. Free fatty acid (arachidonic acid), B. Triacylglycerol (1-palmitic-2-oleic-3-linolenic-
triacylglycerol), C. Phospholipid (L-α-1-myristoyl-2-linoleoyl-phosphatidic acid) 
 
Fatty acids 
A fatty acid consists of an unbranched hydrocarbon chain with a terminal carboxylic acid. 
The fatty acids are classified as saturated or unsaturated depending on whether the 
hydrocarbon chain contains double bonds. Saturated fatty acids (SAFAs) are straight-
chain molecules with no double bonds. Fatty acids with one double bond are classified as 
monounsaturated fatty acids (MUFAs) and those with two or more double bonds as 
polyunsaturated fatty acids (PUFAs). In most of the naturally occurring unsaturated fatty 
acids, the orientation about double bonds is usually cis, rather than trans [31]. The 
orientation is important with respect to the freedom of rotation and flexibility of the 
A.
B.
C.
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molecule. A system of abbreviation has been developed to provide a convenient way of 
referring to fatty acids, Table 1. The number before the colon gives the number of carbon 
atoms and after the colon the number of double bonds. The carbon atoms are numbered 
with the carboxylic terminal as number 1, and double bond locations are designated by 
the number of the carbon atom on the carboxylic side. The location number follows the 
other two numbers, e.g. n-3. Most of the naturally occurring fatty acids have an even 
number of carbon atoms [31]. 
Saturated fatty acids 
In humans, fatty acids are synthesized predominantly in the liver and lactating mammary 
glands and, to a lesser extent, in the adipose tissue [31]. The synthesis of SAFA takes 
place in the cytosol and they are formed from acetyl-CoA. The major product is palmitic 
acid (16:0), although it is myristic acid (14:0) in mammary glands, which can be 
elongated to longer saturated fatty acids. These are in turn converted to MUFAs by 
desaturation [32]. Saturated fatty acids are also supplied by dietary intake. They are found 
in animal products such as meat, milk, cheese and butter. 
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Uptake and synthesis of PUFAs 
Most fatty acids are nonessential for humans. The exceptions are linoleic acid (LA, 18:2 
n-6) and α-linolenic acid (LNA, 18:3 n-3). LA is found in for example corn, rapeseed and 
sunflower oils while LNA is found primarily in rapeseed, flaxseed and soybean oils. 
Longer PUFAs of the n-6 and n-3 families can be produced, to some extent, from LA and 
Table 1. Nomenclature of the most common fatty acids
Systemic name
Sorthand 
designation
Trivial name and 
abbreviations
Saturated fatty acids (SAFA)
Hexadecanoic 16:0 palmitic
Octadecanoic 18:0 stearic
Eicosanoic 20:0 arachidic
Docosanoic 22:0 behenic
Monounsaturated fatty acids (MUFA)
cis-9-hexadecenoic 16:1 n-7 palmitoleic
cis-11octadecenoic 18:1 n-7 cis-vaccenic
cis-9-octadecenoic 18:1 n-9 oleic
cis-13-docosenoic 22:1 n-9 erucic
Polyunsaturated fatty acids (PUFA), n-6 series
all-cis-9,12-octadecadienoic 18:2 n-6 linoleic (LA)
all-cis-6,9,12-octadecatrienoic 18:3 n-6 γ-linolenic (GLA)
all-cis-11,14-eicosadienoic 20:2 n-6 eicosadienoic
all-cis-8,11,14-eicosatrienoic 20:3 n-6 dihomo-γ-linolenic (DHGLA)
all-cis-5,8,11,14-eicosadetraenoic 20:4 n-6 arachidonic (AA)
all-cis-13,16-docosadienoic 22:2 n-6 docosadienoic
all-cis-7,10,13,16-docosadetraenoic 22:4 n-6 adrenic
all-cis-4,7,10,13,16-docosapentaenoic 22:5 n-6 osbond
Polyunsaturated fatty acids (PUFA), n-3 series
all-cis-9,12,15-ocadecatrienoic 18:3 n-3 α-linolenic (LNA)
6,9,12,15-octadecatetraenoic 18:4 n-3 stearidonic
all-cis-8,11,14,17-eicosatetraenoic 20:4 n-3 eicosatetraenoic
all-cis-5,8,11,14,17-eicosapentaenoic 20:5 n-3 timnodonic (EPA)
all-cis-7,10,13,16,19-docosapentaenoic 22:5 n-3 clupadonic (DPA)
all-cis-4,7,10,13,16,19-docosahexaenoic 22:6 n-3 cervonic (DHA)
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LNA. The process occurs predominantly in the endoplasmic reticulum membranes. The 
metabolic pathways for LA and LNA involve the same enzymes, Δ6- and Δ5-desaturases, 
which make the two pathways connected and competing, Fig. 2. 
 
 
 
Fig. 2 The metabolic pathway for polyunsaturated fatty acids linoleic and α-linoleic acids. 
 
The first step in desaturation by Δ6-desaturase activity is the rate-limiting step of this 
pathway. The affinity of Δ6-desaturase for LNA is greater than for LA. However, the 
typically high intake of LA results a in high concentration of LA and low concentration of 
LNA in tissue lipids and preferential conversion of n-6 PUFA [32]. Several studies have 
investigated the potential to convert LNA to eicosapentaenoic acid (EPA), 
docosapentaenoic acids (DPA) and docosahexaenoic acid (DHA). As reviewed by 
LA 18:2 n-6 LNA 18:3 n-3
linoleic acid α-linolenic acid
Δ6-desaturase
18:3 n-6 18:4 n-3
elongation
20:3 n-6 20:4 n-3
Δ5-desaturase
AA 20:4 n-6 EPA 20:5 n-3
arachidonic acid eicosapentaenoic acid
elongation
22:4 n-6 DPA 22:5 n-3
docosapentaenoic acid
elongation
24:4 n-6 24:5 n-3
Δ6-desaturase
24:5 n-6 24:6 n-3
β-oxidation
22:5 n-6 DHA 22:6 n-3
docosahexaenoic acid
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Plourde et al [33] the conversion rate of LNA to EPA is ≈5%, and to DHA <0.5%. 
However, the capacity to synthesize EPA, DPA and DHA seem to be higher in women 
during pregnancy [34]. Several factors are known to affect the Δ6-desaturase activity, and 
therefore the conversion of LA and LNA to longer PUFAs. Examples of nutritional 
factors are low insulin levels and a deficiency of protein and minerals such as iron, zinc, 
copper and magnesium, which are often associated with malnutrition [32]. Other 
negatively affecting factors are alcohol consumption [35] and smoking [36]. 
Long-chain PUFAs can also be supplied through the diet. The n-6 fatty acid arachidonic 
acid (AA) is found in egg and most types of meat while n-3 PUFAs EPA, DHA and DPA 
are only found in marine foods, such as fish, shrimps and crayfish. 
Metabolism of dietary fats 
Current Swedish nutrition recommendations are that 25-30% of the total energy intake 
should be from fat, distributed as 10% SAFA, 10-15% MUFA and 5-10% PUFA of the 
total daily energy intake [37]. Fat is usually ingested as triacylglyceroles, which are 
hydrolyzed to glycerol, free fatty acids, as well as mono- and diacylglycerols in the lumen 
of the small intestine. The hydrolyze products are absorbed by the intestinal epithelial 
cells, where triacylglyceroles are assembled and transported to the mucosal side. 
Triacylglycerols and other fat molecules (cholesterol) are transported by chylomicrons, 
which are fat droplets, surrounded by a phospholipid layer with proteins, termed 
alipoproteins. The chylomicrons transport dietary fats to peripheral tissues where fatty 
acids are released from the triacylglycerols due to hydrolysis by lipases situated on the 
capillary endothelium. The fatty acids are then either combusted for energy production or 
recombined into triacylglycerols for storage. 
Between meals, fat supplies to the tissues are provided via lipoproteins produced in the 
liver. These are lipid droplets, smaller in size than chylomicrons but are also surrounded 
by a phospholipid membrane with specific alipoproteins. Lipoprotein particles are divided 
according to density into very-low density lipoprotein (VLDL), low density lipoprotein 
(LDL) and high density lipoprotein (HDL). 
Placental fatty acid transport 
During pregnancy fatty acids are transported from the mother´s circulation across the 
placenta to the fetus for use as building blocks for cellular membranes. PUFAs, especially 
AA and DHA, are essential for the development of many organs and cells during fetal 
life, including the brain and the retina [38]. The placenta lacks desaturase activity and 
even though isotope studies have shown fetal capacity to produce PUFAs [39], it is not 
known to what extent this occurs and it is generally assumed that the fetal requirements 
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are met by placental transfer of fatty acids [40]. The transported fatty acids can derive 
from free fatty acids in the maternal circulation or they are cleaved off from 
triacylglycerols in lipoproteins by lipoprotein lipases located at the maternal surface of 
the placenta. 
Non-esterfied fatty acids (NEFAs) are transported from the maternal side of the placental 
membrane through the microvillus membrane into the syncytiotrophoblast either via 
diffusion [41] or carrier-mediated transport [42], Fig. 3. The most important proteins in 
placental fatty acid uptake are fatty acid translocase (FAT/CD36), fatty acid transport 
protein with acyl-CoA-synthetase activity (FATP) and plasma membrane fatty acid 
binding protein (P-FABPpm), Fig. 3 [43]. The lipoprotein lipases are also expressed in 
the cytosol of the syncytiotrophoblast, where the NEFAs can be re-esterfied and 
deposited as triacylglycerols for later release and transport into the fetal circulation [43]. 
The placenta is capable of preferential and selective transport of PUFAs to the fetus. 
Haggarty et al [44] found the order of preference to be DHA>AA>LNA>LA. It has been 
suggested that the selectivity depends on the ability of placental lipases to release various 
PUFAs from triacylglycerols [45]. The preferential and selective placenta transport might 
also be dependent on the selectivity of the transport proteins [43].  
 
 
Fig. 3 Model of placental fatty acid transport. LP= lipoprotein, LPL= lipoprotein lipase, NEFA= non-
esterfied fatty acid, TG= triacylglycerols. Adapted after [43]. 
MATERNAL
SYNCYTIO-
TROPHOBLAST
FETAL
NEFA
NEFA
NEFA
LP
LPL
FATP FAT/CD36
P-FABPpm
Passive 
diffusion
Β-oxidation 
TG synthesis 
eicosanoids
FATP
FAT/CD36
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Fatty acids in breast milk 
After birth, breast milk is usually the infant´s first food. It is very rich in nutrients. Mature 
milk contains about 7% carbohydrates, mainly lactose, 0.9-1.3% protein and 3-5% fat 
(mainly as triacylglycerols) [46]. Colostrum contains less saturated fat and more 
unsaturated fat than mature milk [47] but has a lower total fat content. The fatty acids are 
either taken up from plasma chylomicrons through the action of mammary lipoprotein 
lipase, or are synthesized from glycerol and fatty acids in the alveolar cells of the 
mammary gland. The fatty acids derived from chylomicrons may originate either from 
recent dietary intake, be released from maternal adipose tissue or synthesized de novo in 
the maternal liver [48]. 
Biological roles of lipids 
Lipids have profound effects in bodily functions. The most evident biological effects of 
lipids are: 
• use as fuel for generation of energy in the cells 
• components of cellular and intracellular membranes 
• role as intracellular messengers 
• substrates for production as inflammatory mediators 
These functions will be briefly outlined below. 
Role as nutrient 
Fat is stored as triacylglycerols in adipose cells, and that is where the catabolic process 
starts. Triacylglycerols are hydrolyzed to yield glycerol and free fatty acids. The 
hydrolysis products exit the adipocytes by passive diffusion into the blood, where the 
fatty acids bind to albumin. They are released from albumin and taken up by cells, also by 
passive diffusion. Inside the cells, the fatty acids are activated by acylation of coenzyme 
A (CoA) to become fatty acyl-CoAs. These are transported into the mitochondria, which 
are the site of the β-oxidation pathway. During β-oxidation the fatty acid chains are 
broken apart into acetic acid fragments and yield acetyl CoA molecules which enter the 
tricarboxylic cycle to be oxidized to carbon dioxide, water and release energy [31]. 
Membrane lipids 
All cellular membranes consist of phospholipids and cholesterol. The polar phosphate end 
and the non-polar fatty acid part of the phospholipid molecule make the phospholipids 
form lipid bilayers, which make them suitable for cell membranes [32]. The composition 
of fatty acids in phospholipids depends on our diet. There is usually a saturated fatty acid 
at position 1 and an unsaturated in the middle position, position 2. The most common 
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unsaturated fatty acid is AA, but it can also be an n-3 fatty acid such as EPA or DHA 
[32]. 
The composition of fatty acids in membranes strongly influences their fluidity. Membrane 
fluidity increases with an increased proportion of unsaturated fatty acids. The reason for 
this is that PUFA chains are extremely flexible and can rapidly change conformational 
states [49]. The flexibility differs significantly between n-3 and n-6 PUFAs, and the 
fluidity is also affected by the number of double bonds. Thus, the n-3 and n-6 PUFA 
composition affects the physical properties of the membranes, thereby altering protein 
function and trafficking. 
Cellular membranes consist of micro domains called lipid rafts that are rich in saturated 
fatty acids, sphingolipids, cholesterol and glycosylphosphatidylinositolanchored (GPI) 
proteins. The rafts serve as organizing centers for the assembly of signaling molecules, 
influencing membrane protein trafficking and regulating receptor trafficking [50]. The 
composition of lipid rafts can be modified by changes in the dietary intake of PUFAs. 
This could affect activation of proteins within the rafts that are important in both T- and 
B-cell activation [50, 51]. 
PUFAs as intracellular signaling molecules 
Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-activated 
nuclear transcription factors belonging to the nuclear receptor superfamily. There are 
several isotypes of PPAR, where PPAR-γ is the type that is associated with lipids and 
inflammation. PPAR-γ plays an essential role in differentiation of adipocytes and in 
maintaining their special functions such as lipid storage, and also seems to limit 
inflammation by interacting with NFκβ activation. Various PUFAs, especially those of 
the n-3 series, are natural ligands for PPAR-γ, and changes in PUFA intake can thereby 
affect the intracellular signaling and the inflammatory process. 
PUFAs as substrates for inflammatory mediator production 
Several important inflammation mediators are formed from phospholipids, which are the 
major components in cell membranes. As a cell gets an inflammatory signal, the enzyme 
phospholipase A2 (PLA2) binds to cellular membranes and releases arachidonic acid 
which is converted via COX (cyclooxygenase) to PGH2. This intermediate can then be 
converted further to prostaglandins and thromboxanes. All types of cells produce COX, 
but, depending on enzymes downstream of COX, they produce different types of lipid 
mediators when stimulated. There are two forms of COX, COX-1 is constitutively 
expressed, but is produced in larger amounts during inflammation. COX-2 is mostly 
induced during the inflammatory reaction. 
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Alternatively, AA is converted by 5-LOX (lipoxygenase) or 15-LOX. These enzymes are 
only found in inflammatory cells (e.g. granulocytes and mast cells) and are responsible 
for the synthesis of leukotrienes. EPA is a competitive inhibitor for production of 
eicosanoids from AA. Via COX-1, COX-2 and 5-LOX, EPA is metabolized to form the 
3-series of prostaglandins and thromboxanes and the 5-series of leukotrienes. 
Prostaglandin E2 (PGE2) has a number of pro-inflammatory effects including inducing 
fever and vasodilation and enhancing pain. It also acts anti-inflammatorily by suppressing 
production of TNF-α and IL-1 [52]. PGE2 is a strong suppressor of T cell proliferation 
and IFN-γ production [53]. Leukotriene B4 (LTB4) is chemotactic for polymorphonuclear 
neutrophils (PMN) [54]. Thromboxane A2 (TXA2) promotes platelet aggregation. 
Prostaglandin D2 (PGD2) is produced in mast cells during allergic responses and asthma 
[52], and prostaglandin F2α (PGF2α) induces smooth muscle contraction [32]. Leukotriene 
C4 (LTC4), leukotriene D4 (LTD4) and leukotriene E4 (LTE4) promote endothelial cell 
permeability and airway smooth muscle constriction during anaphylactic reactions and 
asthma. 
A novel group of EPA- and DHA-derived metabolites has recently been identified. The 
EPA-derived mediators are termed E-series resolvins and the DHA-derived D-series of 
resolvins and protectins (neuroprotectins D1). The novel mediators are suggested to be 
anti-inflammatory since they are shown to regulate trafficking and migration of 
inflammatory cells and to block transendophelial migration of leukocytes. They are also 
suggested to regulate the levels of pro-inflammatory peptide mediators by inhibiting 
dendritic cell migration and cytokine release. [55, 56]. 
Diet and allergy development 
Several dietary components have been investigated in relation to allergy development, but 
most evidence has been gathered for three dietary components: 
• butter and margarine 
• fish 
• supplements with fish oil or isolated n-3 PUFAs 
Butter and margarine 
In 1997 Black and Sharpe [4] suggested that the increased intake of n-6 PUFAs as well as 
decreased intake of n-3 PUFAs and SAFAs may have contributed to the increased 
prevalence of allergic disease in Western countries. The theory agrees with subsequent 
reports concerning the unification of former East and West Germany, where the 
prevalence of allergies increased rapidly in the eastern part of Germany. This increase 
occurred coincidentally with a change towards a Western lifestyle, including increased 
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intake of margarines rich in n-6 PUFAs such as LA [57]. An increase in margarine intake 
usually means a decrease in butter intake, and in 2001 a Finnish study reported that 
children with atopic eczema or rhinitis ate more margarine and less butter than non-
allergic controls [58]. The positive association between margarine intake and allergy has 
subsequently been shown in several studies [59-62], and the suggested explanation is 
effects of the high PUFA content. 
Fish 
A protective effect from maternal fish intake during pregnancy has been shown on 
eczema [62, 63] and asthma [64] in their offspring. Early introduction of fish into the 
child´s diet has also repeatedly been shown to be associated with less development of 
eczema [5-7] and other atopic diseases [5]. Another inverse association between atopy 
and fish intake is that asthmatic subjects eat less fish than non-allergic ones [63, 65], 
although, some studies have shown negative effects of fish on allergy [66, 67], and a few 
studies observed no associations [68-70]. 
Fish and other marine foods are major sources of the n-3 PUFAs EPA, DHA and DPA, 
and increased consumption of seafood leads to an increased proportion of n-3 PUFAs in 
cell membranes. Other seafood-derived bioactive components that could play a role in 
modulating the risk of allergy development include e.g. vitamin D [71] vitamin E [68] 
and selenium [72]. 
Supplements with fish oil or isolated n-3 PUFAs 
Numerous studies have investigated effects of fish oil or pure n-3 fatty acid 
supplementation on allergy development and reduction of allergic symptoms. After fish 
oil supplementation during pregnancy, Furuhjelm et al [73] reported a lower incidence of 
atopic eczema and food allergy in the infants compared to the placebo group who 
received soy oil rich in n-6 LA. Others show no difference in atopy development in the 
infants [74-76] but less severe eczema symptoms after fish oil supplementation [74, 75]. 
Koch et al reported decreased SCORAD (SCORing Atopic Dermatitis), i.e. less severe 
eczema symptoms, in eczematous adults after supplementation with isolated ethyl esters 
of DHA [77]. 
 
Olsen et al reported a reduction of asthma in children whose mothers received fish oil 
supplement during pregnancy compared to children whose mothers were given olive oil 
[78]. Interestingly, they had a second control group that received no supplements. The 
children in the second control group exhibited diagnostic patterns remarkably similar to 
the group whose mothers had been given fish oil supplements, i.e. children in the olive oil 
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group had a higher prevalence of asthma than children in the fish oil and no supplement 
groups. These results indicate a possibility that olive oil supplementation could, in fact, 
have increased the risk of allergy development in the child. 
 
Mishrshahi et al [79, 80] and Almqvist et al [81] studied children at high risk of 
developing atopic disease, i.e. had a family history of allergy. After supplementation with 
fish oil and use of canola-based oils and spreads (high in n-3 PUFAs, low in n-6 PUFAs) 
in all food preparation from six months of age, they found no difference in atopy 
prevalence at 18 months and five years, respectively. The former group, Mishrshahi et al, 
did follow-up studies on the high-risk children at three [82], five [83] and eight [84] 
years, with no observed effects of fish oil on any clinical outcome relating to allergy.  
 
In all studies mentioned above, the control group was given placebo supplementation of 
oils rich in PUFAs; soy oil, sunflower oil or olive oil, except in Koch´s study where the 
control group got saturated fatty acids; a mix of caprylic acid (8:0) and capric acid (10:0). 
Soy oil and sunflower oil contain high levels of PUFAs, mainly n-6 LA, and olive oil 
contains primarily MUFAs such as 18:1 n-9, but also about 10% PUFAs of which most 
are n-6 PUFAs. In future studies it should be considered how to use n-6 PUFA-rich oils 
as placebo supplementation in control groups, since the effects on allergy is not 
completely defined. 
PUFA pattern and allergy development 
Breast milk PUFA pattern in relation to allergy development 
Breast milk is the major nutritional source for most infants, and allergies often develop in 
early infancy or childhood. Therefore relationships between PUFA composition of breast 
milk and development of allergy have been studied repeatedly. The studies are compiled 
in Table 2. With regard to colostrum, some show no fatty acid differences, but two studies 
report higher DPA and one report higher DHA in breast milk received by children who 
subsequent developed atopic eczema. One study also reported higher LA in breast milk 
given to children who later developed atopic rhinitis. 
When studying fatty acids in mature breast milk which were suckled on of infants who 
later became allergic, the results are also inconsistent. Some report lower levels of EPA, 
other report higher or lower levels of DPA in breast milk received by subsequent allergic 
infants. Further, one study showed higher content of LNA and another study showed 
lower LA in breast milk given to future allergic children. 
Hence, the results reported on associations between PUFAs in breast milk and subsequent 
development of allergy in children is highly inconsistent. 
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Table 2. Fatty acid differences in breast milk received by children who later developed atopy 
            
Reference Subjects Atopic 
criteria 
Controls Sample Fatty acid differences 
            
[85] 22 children with 
atopy 
Clin.hist., 
SPT 
30 3 months Atopics received higher LNA 
and 20:3 n-6 
[86] 24 children with 
atopy 
SPT 15 Colostrum No FA differences 
[86] 21 children with 
atopy 
SPT 61 1 and 3 
months 
Atopics received lower EPA 
at 1 month, and lower DPA 
at 3 months 
[87] 20 children with 
atopy 
Clin.hist., 
SPT 
20 3 months No FA differences 
[88] 17 children with 
atopy 
IgE, 
RAST 
60 Colostrum No FA differences 
[89] 29 children with 
atopic eczema 
SPT 148 Colostrum Atopics received higher DHA 
and DPA 
[90] 13 children with 
atopy 
SPT, 
Hanifin 
21 1 month Atopics received lower EPA 
[91] 11 children with 
atopic eczema 
Clin.hist., 
SPT 
27 3 months Atopics received lower LA 
[92] 6 children with 
atopic ezema 
Clin.hist., 
SPT, 
Hanifin 
19 6 months No FA differences 
[93] 27/ 15 children 
with atopic 
eczema 
Clin.hist., 
SPT 
172/ 105 Colostrum/ 
3 months 
Atopic received higher DPA 
[93] 37/ 25 children 
with atopic 
rhinitis 
Clin.hist., 
SPT 
168/ 100 Colostrum/ 
3 months 
Atopics received higher LA 
in colostrum and higher DPA 
at 3 months 
            
Clin.hist.= clinical history, SPT= skin prick test, RAST= radioallergosorbent test, Hanifin= eczema diagnosed by Hanifin and 
Rajka criteria, FA= fatty acid 
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Breast milk PUFA pattern in relation to maternal atopy 
The PUFA composition of breast milk will be influenced by a number of factors 
including maternal diet and maternal metabolism, both which may be affected by atopic 
disease. The PUFA pattern in breast milk from atopic and non-atopic women has been 
investigated in several studies, to evaluate if children nursed by atopic and non-atopic 
women receive different fat qualities. The reports are summarized in Table 3. The results 
are rather inconsistent, but a few studies report no fatty acid differences and some report 
lower n-3 PUFAs in breast milk from atopic mothers. However, another study shows 
higher DHA in breast milk from atopic mothers. 
 
Table 3. Fatty acid differences in breast milk from atopic and non-atopic mothers 
            
Reference Subjects 
Atopic 
criteria Controls Sample Fatty acid differences 
            
[94] 17 atopic 
mothers 
Clin.hist. 17 1 month Atopics had lower EPA, 
DHA, DPA and 20:3 n-6 
[87] 20 atopic 
mothers 
Clin.hist. 20 3 months Atopics had higher DHA, 
but lower 18:3 n-6 
[95] 168 atopic 
mothers 
Clin.hist., 
IgE 
107 3 months No FA differences 
[96] 43 allergic 
mothers 
Clin.hist. 51 2-3 months No FA differences 
[89] 107/ 60 atopic 
mothers 
Clin.hist., 
SPT 
55/ 36 Colostrum/ 
3 months 
No FA differences 
[97] 144 atopic 
mothers 
Clin.hist. 14 1 month Atopics had lower EPA 
            
Clin.hist.= clinical history, SPT= skin prick test, FA= fatty acid 
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Serum PUFA pattern in relation to allergy 
Allergies may manifest within months after birth. This indicates that the immune 
dysregulation occurs very early during development. A number of studies have therefore 
investigated the PUFA pattern in serum from umbilical cord blood as a possible predictor 
of subsequent allergy. In table 4 studies evaluating PUFA pattern in cord blood are 
summarized. Part A includes studies on cord blood from infants who later developed 
allergies, and in two of these no differences in PUFA composition was observed, while in 
the third lower AA and DHA but higher LA was reported in subsequent allergic children. 
In part B studies including infant with a family history of allergies are compiled. 
According to the reports concerning infants of allergic mothers, they have higher levels of 
AA, EPA and DHA in cord blood. This may indicate that something related to the allergic 
disease has an impact on PUFA supply to the fetus. 
Several studies have also investigated PUFA patterns in serum from children who have 
developed atopy compared to non-atopic children. The rather inconsistent results are 
summarized in table 5. However, some trends in the different results can be seen. The 
fatty acid 18:3 n-6 is reported to be low in serum phospholipids in atopic children in a 
couple of studies, and according to some reports DHA is lower in serum cholesteryl esters 
in children with atopic disease. 
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Table 4. Fatty acid differences in cord blood from children who A. developed atopy later on, B. 
had a family history of atopy 
            
Reference Subjects 
Atopic 
criteria Controls Sample Fatty acid differences 
            
A.           
[98] 9 infants who later 
developed atopic 
dermatitis 
IgE 107 Serum PC Higher LA, but lower 
AA, DHA and 20:3 n-
6 in subsequent atopic 
children 
[86] 19 infants who later 
developed atopy 
Clin.hist., 
SPT 
40 Serum PL No FA differences 
[99] 35 infants who were 
atopic at 3 y 
SPT 35 Whole 
plasma 
No FA differences 
            
B.           
[100] 33 infant with allergic 
mothers 
Clin.hist., 
IgE 
35 Serum PL Higher AA, EPA, 
DHA and 20:3 n-6 in 
high-risk infants 
[101] 25 infants from 
allergic mothers 
Clin.hist., 
IgE 
22 Serum PL Higher AA, EPA, 
DHA and 22:4 n-6 in 
high-risk infants 
[102] 50 infants with family 
history of atopy 
Clin.hist. 50 Plasma PL Lower AA and 22:4 n-
6 in high-risk infants 
            
Clin.hist.= clinical history, SPT= skin prick test, FA= fatty acid, PL= phospholipid, PC= phosphatidylcholine 
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Table 5. Fatty acid differences in serum from atopic and non-atopic children 
            
Reference Subjects Atopic 
criteria 
Controls Sample Fatty acid differences 
            
[86] 16 atopic infants Clin.hist., 
SPT 
35 Serum PL Atopics had higher levels 
of 22:4 n-6 and 22:5 n-6 
[87] 20 atopic infants Clin.hist., 
SPT 
20 Serum PL, 
TG and CE 
Atopics had lower DHA 
in CE and 18:3 n-6 in PL. 
Atopics had higher LA in 
TG. 
[58] 126 children with 
atopic eczema 
Doctor´s 
diagnosis 
126 Serum CE Atopics had lower EPA 
and DHA 
[58] 145 children with 
atopic rhinits 
Doctor´s 
diagnosis 
145 Serum CE No FA differences 
[58] 47 children with 
asthma 
Doctor´s 
diagnosis 
47 Serum CE No FA differences 
[103] 8 children with 
atopic rhinitis 
and/or asthma 
Clin.hist., 
IgE 
6 Plasma Atopics had lower 18:3 n-
6 
[92] 6 children with 
atopic eczema 
Clin.hist., 
SPT, 
Hanifin 
19 Serum PL Atopics had lower 18:3 n-
6, but higher EPA 
            
Clin.hist.= clinical history, SPT= skin prick test, Hanifin= eczema diagnosed by Hanifin and Rajka criteria, FA= fatty acid, PL= 
phospholipid, TG= triacylglycerol, CE= cholesteryl ester 
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Potential phases of action of PUFAs on immune functions 
Allergy denotes immune mediated hypersensitivity, defined as the appearance of 
symptoms when a previously sensitized individual is exposed to the antigen to which 
she/he has developed an immune response. The proposed effects of PUFA intake on 
allergy could occur on one or several of the following levels: 
• the sensitization phase 
• expansion and maturation of T lymphocytes 
• expansion of B cells and maturation into IgE-producing plasma cells 
• the symptom phase in which blood vessel tonus and permeability are affected and 
inflammatory cells are recruited into the tissues 
The phases will be briefly described below as a background for understanding the 
potential immune modulating effects of PUFAs. 
Sensitization phase 
Adaptive immune responses start with presentation of the antigen by an antigen-
presenting cell (APC), usually a dendritic cell, to naïve T cells. This presentation occurs 
in the lymph nodes to which the antigen is brought via the lymph, or carried within 
dendritic cells from mucosal membranes or the skin. Naïve T and B cells circulate 
through the lymph nodes in search of their specific antigen. 
Naïve CD4+ T cells (termed helper cells) recognize and interact with peptides presented 
on MHC II molecules, become activated, and start to proliferate. They can then 
differentiate into various effector subsets, Fig. 4. The route of differentiation is thought to 
depend on the antigen, the activation state of the APC, and the surrounding environment. 
Mature and activated T cells are termed effector cells and participate in immune 
responses aiming to eliminate the offending antigen and resolve the infection. After this 
initial immune response, most of the effector cells die, while a fraction survive and 
become long-lived memory cells. 
The Th1 differentiation pathway is stimulated by bacteria and strong adjuvants such as 
Freund´s complete adjuvant (mineral oil containing dead mycobacteria). Activated APCs 
secrete IL-12 which stimulates maturation of Th1 cells. Th1 cells produce the cytokine 
IFN-γ which further induces IL-12 production from APCs. IFN-γ also activates the killing 
capacity of macrophages. Th1 cells are responsible for delayed-type hypersensitivity, 
which is a hallmark of contact allergy. A person who has memory Th1 cells against a 
contact allergen is termed sensitized and can develop symptoms upon renewed encounter 
with the same antigen. 
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Fig. 4 T cell subsets. A naïve CD4+ T cell can differentiate into diverse effector cells (Th1, Th2, Th17 and T 
reg) upon activation, which are influenced by signals, such as cytokines from the antigen-presenting cell 
and the environment. 
 
The Th2 pathway is activated in response to helminthes and allergens and by the adjuvant 
alum (Al(OH)3). Th2 cells produce IL-4, which is a growth factor for Th2 cells. IL-4 also 
activates B cells to produce antibodies. Other cytokines produced by Th2 cells are IL-13, 
which enhance IgE production, and IL-5, which increases the production of eosinophils in 
the bone marrow. 
Other T cell subsets include Th17 cells that are involved in neutrophil recruitment and the 
production of defensins, antimicrobial peptides, by skin and mucosal epithelium. 
Regulatory T cells (Treg) inhibit immune responses by blocking activation and functions 
of other effector T cells [104]. 
The signals from the APCs that are responsible for the preferential maturation of the 
naïve T cells along the various pathways exemplified above are poorly known. 
Production of IL-12 is inhibited by bacterial products [105] and favors maturation along 
the Th1 pathway. Production of PGE2 has been linked to maturation of Th2 cells and 
vitamin A metabolites, and the cytokine TGF-β for maturation of regulatory T cells. 
IgE production 
IgE is produced by plasma cells located in lymph nodes. Plasma cells derive from 
antigen-stimulated B cells that have been stimulated by recognition of their specific 
antigen and have received help from activated helper T cells. Naïve B cells produce only 
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IgM, but renewed or continuous antigen stimulation leads to a change in the 
immunoglobulin isotype to IgG, IgA or IgE. This is termed “switch” and depends on 
signals supplied by activated helper T cells, in the case of Th2 cells, IgE. A person who 
produces IgE antibodies against an allergen is termed sensitized. Sensitization is a 
prerequisite for the appearance of symptoms upon renewed encounter with the allergen. 
The symptom phase of allergy 
Allergy is immunologically implied hypersensitivity towards a harmless antigen 
(allergen). Allergies may originate from different types of immune reactions, either 
immediate hypersensitivity or delayed-type hypersensitivity (DTH). 
 
A. Immediate/IgE-mediated allergy 
The immediate type of allergy is also called atopic allergy and is mediated by IgE 
antibodies. IgE antibodies bind to mast cells via their membrane bound Fcε-receptor. 
When allergens are inhaled or ingested, it binds to the IgE antibodies, and mast cells are 
activated and start to degranulate. Histamine is secreted and gives rise to vasodilation and 
increased vascular permeability. Activated mast cells also start producing leukotrienes C4, 
D4 and E4 from AA, which contract smooth muscles in the bronchi and initiate mucus 
release from mucus-producing cells. Mast cells, T cells and macrophages in the 
inflammatory focus produce cytokines which recruit eosinophils and T cells to the 
inflammatory site. Eosinophils degranulate and also synthesize a range of different lipid 
mediators. However, very little is known about the functions of the eosinophilic granula 
substances or the lipid mediators. Examples of IgE-mediated allergic manifestations are 
asthma, hay fever and some food allergies. 
 
B. Contact allergy (DTH) 
Contact allergy is an example of delayed-type hypersensitivity, DTH, in which Th1 
lymphocytes and the Th1 cytokine IFN-γ are important actors. Small molecules that can 
cross the skin barrier, and to which the individual has developed memory Th1 cells, elicit 
activation of these T cells. Th1 cells produce IFN-γ that in turn activates tissue 
macrophages with increased production of chemotactic cytokines and accumulation of 
more T cells and monocytes in the tissue. 
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Potential immunomodulating effects of PUFAs 
Membrane fluidity and lipid rafts 
When the body experiences an alteration in fatty acid supply, the composition of the 
membrane phospholipids of immune cells is modified. If the membrane proportion of n-3 
PUFAs increases, the n-6 PUFAs decrease. An altered PUFA composition in 
phospholipids changes the fluidity of the membranes. This affects receptor functioning, 
the activity of membrane bound enzymes and signal-transduction mechanisms [106]. 
It is proposed that changes in so called lipid rafts are significant for activation of Th1 
cells, in contrast to Th2 activation. Lipid rafts are micro domains in plasma membranes 
that are platforms for cell activation and signaling between cells [50]; due to changes in 
PUFA composition in lipid rafts, it affects T cell responses [51]. 
PPAR-γ activation 
The PPAR-γ transcription factor is activated by n-3 PUFAs. PPAR-γ acts in an anti-
inflammatory way by interacting and disturbing the NFκβ activation. It also stimulates the 
degradation of inflammatory eicosanoids and inhibits production of TNF-α, IL-1β, IL-6, 
IL-8, VCAM-1, acute phase proteins and COX-2 [107, 108]. 
Affects on antigen-presenting cells 
Dendritic cells (APCs) treated with DHA have been reported to have a reduced ability to 
activate naïve CD4+ T cells [109]. The expression of transcription factors involved in 
differentiating pathways of Th1 (Tbet) and Th17 (RORγt) cells was reduced by DHA 
treatment, and production of IFN-γ and IL-17 were also reduced. However, the 
expression of the transcription factor involved in differentiation into Treg cells (FoxP3) 
was increased. 
APCs which mature in the presence of AA-derived PGE2, produce high levels of IL-10, 
but no IL-12 [110, 111]. The PGE2-APCs promoted the development of Th cells that 
produced high levels of IL-4 and IL-5. The results suggested that elevated levels of PGE2 
promote the Th2-mediated immune response. 
Effects on inflammatory responses 
Meijerink et al [112] investigated the immunomodulating effects of the DHA metabolite 
docosahexaenoylethanolamide (DHEA). They showed that DHEA reduced Th1-mediated 
inflammation through decreased production of the chemokine MCP-1 and the 
vasodilating compound NO. 
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Intake of n-3 PUFAs has also been shown to interfere with thrombocyte activation and 
coagulation, which are intimately linked to inflammation and immunity, especially in 
Th1-driven immune reactions [113]. 
Concluding remarks 
Altogether, dietary intake of PUFAs and PUFA pattern in serum and breast milk seem to 
be associated with allergy or allergy development. The most consistent result regarding 
dietary intake of PUFAs is the high intake of margarine and low intake of butter among 
allergic subjects. Several studies report associations between high fish intake and low 
prevalence of allergies, however reports with contradictory results are also proposed. 
Supplementation with fish oil or isolated n-3 PUFAs also show diverse results with 
respect to allergy development. 
Concerning studies investigating PUFA pattern in breast milk and serum in relations to 
allergy development or maternal atopy the results are also fairly inconsistent. Many 
surveys include subjects with different allergic manifestations, the groups of participants 
often include low numbers of subjects and sample collection occurs at different times or 
ages. These factors might affect the PUFA pattern, differences between the groups and 
makes it hard to compare different studies with each other. 
The overall inconsistency of reported associations between PUFAs and allergies opens up 
to further investigation of these presumed relations. 
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STUDY DESIGN AND METHODOLOGICAL CONSIDERATIONS 
DTH model (Th1) Airway hypersensitivity model (Th2)
Footpad swelling Eosinophil infiltration in lungs
In vitro proliferation Total serum IgE
Cytokine production Specific IgE in serum
Serum fatty acids continously Serum fatty acids continously
Mice fed diets supplemented with fish oil (rich in n-3 PUFAs) or sunflower oil (rich in n-6 PUFAs)
Animal models (Paper 3)
Questions
2. Are PUFAs consumed in the body during allergic reactions?
1. Do diets supplemented with n-3 or n-6 PUFAs affcct different allergic immune reactions and how?
Models
Animals
1 1 1
2 2 2
1 month: Breast milk Birth: Umbilical cord blood Birth: Umbilical cord blood
Serum 13 years: Serum 1 month: Breast milk
Maternal serum
4 months: Breast milk
Child serum
1 month: Food frequency questionnaire1 13 years: Food frequency questionnaire1 Pregnancy: Food frequency questionnaire1
1 month: 24-h dietary recall1,2
24-h dietary record1,2
4 month: 24-h dietary recall1,2
24-h dietary record1,2
1 Food components
2 Nutrients
Methods
Cohort I (Paper 1) Cohort II (Paper 2) Cohort III (Paper 4)
Questions
Do allergic and non-allergic women have 
different PUFA patterns in breast milk and are 
these patterns related to the diet?
Do allergic manifestations give rise to different 
PUFA profiles in serum?
Are there differences in dietary habits between 
farming women and non-farming women, and 
are such differences related to protection 
against allergy development?
Do different allergic manifestations give rise to 
different PUFA profiles in breast milk and 
serum?
Can PUFA pattern in umbilical cord blood 
predict the risk of subsequent allergies?
Are there differences in breast milk and serum 
PUFA pattern from farming and non-farming 
mothers and children?
Subjects
Children with different allergic manifestations Farming/Non-farming mother-infant pairs
Lactating women with different allergic 
manifestations
Fatty acid analyses
Dietary analyses
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The thesis is based on four separate studies that include three human studies and one 
animal study. Dietary habits in farming families and the relation to protection against 
allergy are investigated in a birth-cohort study. In the retrospective case-control study 
PUFA pattern in umbilical cord blood is studied, and in the remaining human study fatty 
acid patterns in breast milk and serum are studied in relation to different allergic 
manifestations. Associations between these breast milk and serum fatty acid pattern and 
dietary intake of fatty acids are also evaluated. In the animal study, effects on different 
immune reactions in diets rich in n-3 and n-6 PUFAs are compared. 
Study design 
Cohort I (Paper 1) 
This study was designed to investigate whether PUFA pattern in breast milk and serum 
differ between allergic and non-allergic women, and to evaluate whether different allergic 
manifestations give raise to different PUFA profiles. The study population comprised 45 
women who gave birth between September 2005 and September 2007, 18 of whom were 
from the city of Göteborg in southwestern Sweden and 27 living in a rural area around 
100 km from Göteborg. The latter 27 women were originally recruited to the FARM 
FLORA study (described under Cohort III). The women were enrolled at the respective 
antenatal clinics and filled in a questionnaire that attempted to identify doctors diagnosed 
allergic disease. Women with a clear history of asthma, allergic rhinitis and/or atopic 
eczema were included, as were a number of non-allergic women without allergic 
symptoms. To confirm the atopic/non-atopic state, a blood sample was drawn and 
analyzed for total IgE and specific IgE antibodies. 
Blood and breast milk samples were taken one month postpartum for fatty acid analyses, 
and all women completed a food frequency questionnaire (FFQ) on dietary habits during 
pregnancy and lactation. 
Cohort II (Paper 2) 
This study was designed to assess allergy development in a prospective birth cohort of 
about 1200 children, all living in Jämtland in the Northern part of Sweden. They were 
born during the period February 1996-January 1997 (described in detail in [114]). 
At the age of 13, three groups of subjects were selected to participate in the retrospective 
case-control study. The subjects were selected on the basis of allergic disease diagnosis, 
since the objectives were to study fatty acid pattern in serum in relation to different 
allergic manifestations. 44 children with atopic eczema were included; 58 children with 
respiratory allergy (hay fever and/or asthma) and 52 non-allergic controls with negative 
skin prick test and no history of atopic diseases. Blood samples had been taken at birth 
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(umbilical cord blood) and stored at the Department of Pediatrics at Östersund Hospital. 
For this study, a blood sample was collected at 13 years of age for fatty acid analyses. 
Cohort III (Paper 4) 
The FARM FLORA study is a birth-cohort study that enrolled 66 children born 
September 2005-August 2008 where the objective was to investigate why the farming 
environment protects against allergy development. Two potential explanations were 
studied in detail:  
• The farming environment is characterized by increased exposure to 
microorganisms, through contact with animals and through food. This would 
accelerate the maturation of the infant´s immune system and thereby facilitate the 
development of tolerance against food and other harmless substances. 
• Foods that are consumed on small family farms reduce inflammation and/or 
modulate the immune system in a way that protects against allergy development, 
e.g. by their fatty acid composition or other bioactive compounds in foods. 
The families lived in a rural area around 100 km from Göteborg. Mothers-to-be were 
recruited at antenatal clinics and via advertisement in regional daily newspapers and 
farming trade magazines. Upon recruitment, they filled in questionnaires concerning the 
farm, living conditions, siblings, pets, smoking habits, allergies in the family and food 
frequencies during pregnancy. Blood samples were taken from the parents to analyze IgE 
antibodies. Blood, saliva and feces samples were collected from the children according to 
Fig. 5. Dietary anamneses were taken from mothers during lactation, and from children, 
as soon as they started to eat solid foods. During dietary assessment of the children, 
samples of all ingested foods during 24 h were collected. 
 
 
 
Fig. 5 Study design in the Farm flora study 
Feces samplesBlood samples
3d1w 2w 1m 2m 4m 6m 12m 18m 36m
Clinical examinationSaliva samples
Dietary assessment and food samples
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In the work reported in paper 4, the following samples were analyzed concerning fatty 
acid status, composition and intake: (i) blood samples from birth (umbilical cord) and 
four months, (ii) breast milk from one and four months, (iii) dietary data from pregnancy 
(FFQ), one and four months. 
Animal models (Paper 3) 
Mice were fed diets supplemented with fish oil (rich in n-3 PUFAs) or sunflower oil (rich 
in n-6 PUFAs) or a control diet of regular mouse chow. The effects of the different diets 
were evaluated in two allergy models. Th1-mediated allergic reactions were studied in a 
delayed-type hypersensitivity (DTH) model, while Th2 reactions were surveyed in an 
eosinophil-mediated airway hypersensitivity model. Dietary intake was monitored by 
fatty acid analyses of continuous blood sampling. 
In the DTH model, a Th1-mediated reaction takes place, in which the main actors are Th1 
lymphocytes and the cytokine IFN-γ. NK cells, IL-12 and TNF also play key roles in this 
type of hypersensitivity reaction. Sensitization in the DTH model was measured by 
excising draining lymph nodes and stimulating the lymphocyte cells with the model 
antigen (OVA). Cell proliferation was measured after 7 days, and cytokine production 
was analyzed in the supernatant from the cell suspensions. 
The airway model simulates an immediate type of IgE-mediated allergy, which involves 
mast cells and eosinophils, among others. In this model, sensitization was measured as 
OVA-specific IgE and total serum IgE. Infiltration of eosinophils into the lungs was also 
measured. 
Fatty acid analysis 
The PUFA pattern was analyzed in breast milk and serum samples using a direct 
transesterfication method, where both esterfied and free fatty acids were directly 
converted into methyl esters without prior fat extraction [115]. The direct-methylation 
technique had several advantages over traditional methods including fat extraction. It was 
less time-consuming, and gave a more complete recovery since fatty acids were directly 
freed from the different lipid classes of the samples. Because of the single-step procedure, 
there were fewer steps in which lipids could be lost and there was no need to add 
antioxidants since auto-oxidation does not occur after methylation [115]. 
In human serum, PUFA composition was analyzed in the phospholipid fraction since it 
reflects the long-term fatty acid intake while measurement in total lipids in serum gives a 
picture of the most recent intake. Phospholipid composition was determined by extracting 
fat from serum with chloroform and methanol [116] and then obtaining the phospholipids 
by separation on aminopropyl solid phase extraction columns [117]. 
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Whole mouse blood was analyzed regarding PUFA composition in the animal model, 
foremost because of the small sample volume.  
Breast milk PUFAs were analyzed in the total lipid fraction by the same direct 
transesterfication method described above. 
Dietary assessment 
Dietary data were collected using three different methods. Dietary habits during 
pregnancy (Paper 1, 4) and at 13 years of age (Paper 2) were evaluated by food frequency 
questionnaires (FFQ) based on the Northern Swedish 84-item FFQ [118]. Maternal food 
and nutrient intake during lactation (Paper 4) was surveyed using a combination of 24-h 
dietary recall and 24-h dietary record. All three methods have advantages (+) and 
limitations (-). 
 
FFQ: 
+ gives information covering a long time interval 
+ registers dietary habits  
+ is insensitive to intra-individual, day-to-day variation in food and nutrient intake 
- risks over- and underestimation 
- relies on memory 
- relies on perception of serving sizes 
 
24-h dietary recall: 
+ difficult to bias because of unannounced interviews 
+ guidance by the interviewer to minimize memory biases 
- limited ability to register habits 
- relies on perception of serving sizes 
 
24-h dietary record: 
+ easy to remember because of registration concurrent to intake 
+ possibility to use kitchen scales or measuring tools to estimate weights or amount in an 
accurate way 
+ easy to report exact estimations with respect to brands, content and preparation 
- risk of adapting the diet to the better at the registration day 
 
By using combinations of all three dietary assessment methods, our aim was to maximize 
the chance of recording differences between farmer´ and non-farmer´ diets and of 
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obtaining high quality data (i.e. giving more emphasis to dietary patterns recorded by 
more than one method). 
Quantification of immune mediators 
Specific and total IgE 
OVA-specific IgE were analyzed in serum from mice included in the airway 
hypersensitivity model to measure sensitization. Titres of OVA-specfic IgE were assayed 
by passive cutaneous anaphylaxis [119] using Sprague-Dawley rats (Scanbur AB).  
Total serum IgE concentrations were determined by sandwich ELISA (BD Biosciences 
Pharmingen).  
In vitro proliferation assay 
To measure sensitization in the DTH model, lymph nodes were excised and single cells 
were suspended and stimulated with OVA. After two days of incubation, supernatant was 
collected for cytokine analyses and cell proliferation was measured after seven days. 
Cytokines 
Cytokines (IFN-γ, TNF and IL-6) were assayed in supernatants from cell suspensions of 
excised lymph nodes in the DTH model using cytometric bead array (CBA; BD 
Biosciences, San Jose, CA, USA). CBA is a method in which several different cytokines 
are measured at the same time in the same sample. It is less time-consuming and more 
suitable for small sample volumes than are conventional methods such as ELISA. 
Statistical analysis 
Multivariate analysis 
Multivariate analyses are particularly suitable for analyzing large data sets consisting of 
numerous variables. With principal component analysis (PCA) an initial over-view of 
possible clustering of observations is obtained on the basis of all variables 
simultaneously. The original set of correlated variables is combined into a small number 
of new variables, termed “latent variables”, “principal components” or “score vectors”, 
each of which accounts for as much of the variance of the original data as possible and 
which are also not correlated to one another [120]. In projections to latent structures by 
means of partial least square (PLS), the “latent variables” that co-vary maximally with a 
selected Y variable, for example a certain clinical condition, are searched for. PLS is then 
a regression extension of PCA [121]. By using PLS with discriminant analysis (PLS-DA), 
predetermined classes of observations are separated on the basis of all variables. The 
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variables that contribute to this separation can then be identified. These methods permit 
an evaluation of differences in variables without the risk of problems with mass 
significance, the need for normal distribution of data and the need for strict independence 
among variables, which are caveats of conventional statistics when used with this type of 
data. 
Multivariate statistical analyses were performed using Simca-P+ 12.0 (Umetrics, Umeå, 
Sweden). 
Univariate analysis 
Univariate analyses were performed with SPSS 15.0 (Papers 1 and 3) and with PASW 
Statistics 18.0 (Papers 2 and 4). The Mann Whitney U-test was used to determine group 
differences concerning dietary data, fatty acids in serum/breast milk and immune 
mediators, etc., that were not normally distributed. Spearman´s rank correlation was used 
to test for associations and Wilcoxon´s signed-rank test for within-individual differences 
in serum FA measured at different time points. P values < 0.05 were considered 
significant. 
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RESULTS AND DISCUSSION 
Allergic women have low PUFA levels in breast milk and serum, despite high 
fish intake 
With the aim to investigate whether fatty acid pattern could be related to different allergic 
manifestations, we analyzed 45 women for the fatty acid pattern in serum and breast milk. 
These women were either non-allergic (n=22), had respiratory allergy (n=7), had 
respiratory allergy combined with eczema (n=16) or had eczema alone (n=1). Breast milk 
was collected one month after delivery of the child. The results were analyzed by the 
multivariate pattern analysis method PLS-DA in which groups can be separated on the 
basis of a very large number of variables. We found that women with an allergic 
phenotype that included eczema had a fatty acid pattern in breast milk and serum that 
differed significantly from that of women who were non-allergic or had isolated 
respiratory allergy, Fig. 6. 
 
The two latter groups overlapped almost completely, indicating that they had very similar 
fatty acid patterns in breast milk and serum. When examining which fatty acids that were 
responsible for the separation of the women with eczema from the rest, we found that 
eczematous women had significantly lower levels of several PUFAs in breast milk and 
serum compared to the other two groups. This included the total level of PUFAs, as well 
as lower levels of the n-3 PUFAs EPA, DHA, DPA and the n-6 PUFA AA. 
The deviating fatty acid patterns of the women with combined respiratory allergy and 
eczema might depend on the extent of disease. The eczema group included women who 
suffered from allergy involving two organ systems (skin and airways). They were also 
sensitized towards a greater number of allergens than the women with isolated respiratory 
allergy. Another possibility is that partly different types of immune reactions are 
involved. Thus, in atopic eczema, both Th1, Th2 and CD8+ T cells are involved, while 
respiratory allergy may be dominated more by Th2-mediated reactions. 
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Fig.6 A. PLS-DA score plot showing an overview of the separation of the three clinical groups: healthy 
(non-allergic), eczema+respiratory and isolated respiratory allergy. B. PLS-DA loading plot displaying the 
variables that contributed most to the class separation. 
 
Regarding the low levels of PUFAs observed in allergic women with respiratory allergy 
and eczema compared with non-allergic women, several possible mechanisms can be 
proposed: 
1. Low dietary intake of PUFAs may predispose to allergy development. However, 
when we analyzed dietary data obtained by FFQ, we found that women with 
extensive allergy including eczema had the highest intake of lean fish, shellfish 
and total fish intake. Eczematous women thus, had low n-3 PUFA levels despite a 
high fish intake. Further, the highest intake of fatty fish was seen in women with 
isolated respiratory allergy, Fig. 6B, suggesting that their “normal” PUFA levels 
were in fact, lower than would be expected according to their dietary intake. 
2. High levels of PUFAs could protect against eczema/extensive allergic disease. 
Low levels of PUFAs despite high fish intake could be caused by increased levels 
of exercise in the allergic women. Helge et al [122] showed that exercise leads to 
increased incorporation of EPA and DHA in muscle phospholipids. If other 
PUFAs are also incorporated in muscle cell membranes and if women with 
extensive allergy are more physically active than non-allergic women, this could 
explain the lower amounts of PUFAs in the former group. 
3. High levels of PUFAs could confer protection to eczema/extensive allergic 
disease. Low levels of PUFAs despite high fish intake could depend on a relative 
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dysfunction of Δ6- and Δ5-desaturases. These enzymes elongate LA and LNA to 
AA, EPA, DHA and DPA. Several other studies have suggested that enzymatic 
dysfunction could explain low n-3 PUFA levels in allergic subjects [86, 123, 124]. 
4. High levels of PUFAs could give protection from eczema/extensive allergic 
disease. Low PUFA levels despite high fish intake could depend on a relative 
dysfunction of PUFA uptake in the intestines or reduced transport from serum to 
breast milk. 
5. Low PUFA levels in women with extensive allergic disease could be a result of 
consumption of PUFAs during the allergic inflammation. AA, EPA and DHA 
could be consumed for e.g. production of mediators produced during 
inflammation, incorporated into rapidly dividing cells, or consumed in other 
processes connected to allergic inflammation. 
 
High PUFA levels in cord blood may be a risk factor for subsequent allergy 
development 
To investigate whether or not PUFAs exert a protective effect on allergy development, we 
examined PUFA levels in the cord blood of a prospective birth-cohort assembled in 
Jämtland in 1998. Serum had been stored frozen and we selected three clinical well-
defined groups: children who had atopic eczema, but no other type of allergy at 13 years 
of age, children who had asthma and/or hay fever, but no other type of allergy at 13 years 
of age, and completely non-allergic children, who were also negative in skin prick tests 
for all tested potential allergens. 
 
We observed that the cord blood of infants who later developed allergy had higher PUFA 
levels at birth than infants who remained non-allergic. This was true of both n-3 and n-6 
PUFAs, e.g. AA (n-6) and DHA (n-3), Fig. 7, as well as most of the examined PUFAs 
(see paper 2). AA and DHA are two of the most important fatty acids during fetal 
development. AA is a major constituent of vascular endothelium membranes, while DHA 
is essential for the development of the brain and retina [38]. Thus, DHA and AA are 
preferentially transported from the mother to the fetus across the placenta [44]. 
 
Our results thus suggested that PUFAs, both of the n-3 and n-6 series, in cord blood were 
not protective against allergy development but were rather associated with a greater risk 
of developing IgE-mediated allergy. This finding was surprising considering the 
multiplicity of studies in which supplementation with n-3 PUFAs to pregnant and 
lactating women was used in an attempt to prevent allergy development. 
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Differences in PUFA levels in the fetus could depend on differences in maternal blood 
PUFA levels, differences in maternal-fetal transport capacity and/or differences in fetal 
production of PUFAs. Regarding the first possibility, a constant supply of PUFAs to the 
fetus is thought to operate so as to ensure PUFA availability during critical periods of 
fetal development [125]. Theoretically, a genetic variability of both placental lipases and 
placental fatty acid transport proteins might affect the transfer of fatty acids across the 
placenta.  
Stable isotope studies have demonstrated that premature infants are able to synthesize AA 
and DHA at an age when they would still developmentally be dependent on the placenta 
[39]. A difference in the fetal ability to produce PUFAs could thus offer a possible 
explanation for the presently observed disparity in cord fatty acids. 
 
 
Fig.7 Fatty acids (% of total fatty acids) in cord serum phospholipids from infants who later developed 
allergy or stayed non-allergic (**P<0.01, AA= arachidonic acid, DHA= docosahexaenoic acid, LC-
PUFAs= long-chain polyunsaturated fatty acids). 
 
PUFAs in allergic and non-allergic children at 13 years of age 
Serum was also obtained and analyzed for PUFA pattern at 13 years of age in the allergic 
and non-allergic children in the birth cohort. No differences in serum fatty acids were 
observed between allergic and non-allergic 13-year old adolescents as regards PUFA 
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pattern. According to the FFQ done at 13 years, the eczema group consumed more low-
fat milk, low-fat cheese, sausage and bacon than the non-allergic group. The respiratory 
group had a higher intake of sausage than the non-allergic controls. Fatty pork products 
contain much saturated fat. However, the differences in dietary intake were not extensive 
enough to be reflected as fatty acid differences in serum. 
The clear difference in PUFA pattern at birth between the children who later developed 
allergy or remained non-allergic, and the absence of such a difference between the same 
groups at 13 years of age, could indicate either that the cord blood concentrations of 
PUFAs were mainly dependent on maternal factors (dietary intake, PUFA elongation, 
transplacental transport) while the 13-year serum PUFA pattern naturally depended on the 
child´s own dietary intake or PUFA elongation. As the allergic phenotype is imprinted 
very early in life [126], PUFA patterns at birth are likely to be much more important for 
allergy development than later patterns. Secondly, as suggested in study 1 on allergic 
women, allergic children may experience enhanced consumption of PUFAs in the body 
during allergic inflammation. Thus it is not impossible that the allergic children could 
ingest and/or produce (by elongation) more PUFAs than non-allergic children, but that 
this does not show up as increased PUFA levels in blood, because PUFAs are consumed 
during allergy. 
Diets rich in PUFAs have different effects in Th1- and Th2-mediated 
hypersensitivity mouse models 
Mouse studies were performed to investigate effects of high dietary intake of PUFAs on 
DTH and IgE-mediated hypersensitivity reactions. Mice in both models were fed either a 
control diet (regular mouse chow), or a diet supplemented with fish oil (rich in n-3 
PUFAs) or sunflower oil (rich in n-6 PUFAs). 
We selected two hypersensitivity models: In the first model, delayed-type 
hypersensitivity (DTH), known to be exerted by CD4+ T cells was elicited. Immunization 
with ovalbumin (OVA) in Freund´s complete adjuvant was used to elicit CD4+ T cells. 
Later injection of OVA into the skin (here: paw) led to accumulation of CD4+ T cells and 
monocytes within 24-48 h. In the second model, injection of the model antigen OVA 
together with the adjuvant alum, was performed to induce production of IgE antibodies. 
Challenge with OVA in the airways led to IgE-mediated hypersensitivity with an 
accumulation of eosinophils in the airways. 
We found that fish oil supplementation reduced some immune activity parameters in the 
DTH model, foremost proliferation and cytokine production by lymphocytes in draining 
lymph nodes when stimulated with the recall antigen, OVA, Fig 8 A. Animals that were 
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fed sunflower oil also showed decreased IFN-γ production, although to a lesser extent 
than mice fed a diet supplemented with fish oil, Fig 8 A. 
In the airway hypersensitivity model, we noted that mice that were given a diet 
supplemented with fish oil had higher levels of antigen-specific IgE in serum and had a 
higher proportion of eosinophils in the bronchoalveolar fluid, than mice fed a control diet, 
Fig. 8 B. 
 
 
 
 
 
Fig. 8 Effects on fatty acid supplementation in A. DTH model: Proliferation of cells from draining lymph 
nodes and proliferation of IFN-γ. B. Airway model: Serum levels of OVA-specific IgE and proportion of 
eosinophils from bronchoalveolar lavage fluid. 
OVA-induced T cell proliferation OVA-specific serum IgE 
IFN-γ production Eosinophils in BAL fluid 
A. DTH model B. Airway model 
 41 
 
The results demonstrate that a fish oil diet suppresses effector functions of Th1-type T 
cells (less production of IFN-γ) while increasing IgE production, which depends on the 
action of Th2 cells. The reduction of the Th1-reaction could depend on a lower 
prevalence and/or functional activity of the Th1 memory cells, while we found no 
evidence for any direct anti-inflammatory effects of fish oil. Thus, the marginally 
decreased DTH could be explained by a reduced prevalence/functional activity of OVA-
specific memory Th1 cells. 
The increased IgE production in mice fed fish oil rich in n-3 PUFAs was very interesting 
and somewhat controversial, as support has been reported for fish oil to reduce allergy 
[73, 74, 127]. However, there are also many studies that have not found a beneficial effect 
of fish oil on allergy development [76, 80, 128, 129]. 
Early feeding of fish is associated with protection against eczema [5-7]. Eczema is a 
complex condition involving both Th1 and Th2 CD4+ T cells [130], where Th1 cells 
induce the chronic inflammation reaction with prolonged effect [131]. CD8+ cells are also 
prevalent in the early phase of the disease [132]. If fish or fish oil is able to reduce Th1-
mediated reactions, this might explain why diets including fish could protect against 
eczema. However, one must also consider the possibility that other components in fish are 
responsible for the protective effects, such as vitamin D, vitamin E or selenium. 
Reduction of PUFAs during the allergic inflammatory reaction 
A significant reduction of PUFAs was seen in the animal study during the challenge 
phase and the resulting allergic inflammatory reaction. The decrease was most obvious in 
the airway model, and the drop in serum EPA levels during the challenge phase correlated 
positively with the serum levels of OVA-specific IgE. The quite drastic fall in serum 
PUFA levels, despite continued intake, indicate a pronounced consumption of long-chain 
PUFAs during the inflammatory process. 
Consumption of PUFAs was much less pronounced in the DTH model. However, footpad 
swelling correlated positively with reduction in serum EPA levels during the challenge 
phase. The lesser amount of PUFA consumption could depend on a difference in size of 
the affected organs; one paw in the DTH-model as compared to the entire respiratory 
system in the asthma model. A higher consumption of PUFAs in the respiratory model 
may also depend on eosinphilic involvement, since eosinophils are known to be versatile 
producers of products from PUFAs. Further, we noted a reduction of PUFAs during the 
Th2-sensitization phase but not Th1-sensitization phase. This could be due to an 
enhanced production of lipid mediators that affect the outcome of the interaction between 
APCs and naïve T cells, leading to Th2 maturation. In accordance, the lipid mediator 
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PGE2 that is produced from AA promotes the development of APCs that favor Th2 
maturation. 
Consumption of PUFAs during allergic reactions would explain the low levels of PUFA 
in lactating women with an extensive degree of allergy including eczema, compared to 
non-allergic women and women with isolated respiratory allergy. The group of women 
with an extensive degree of allergy suffered from both skin and respiratory atopy 
involving more than one organ and a greater number of allergens compared to the isolated 
respiratory group. The extensive allergic inflammation would probably consume more 
PUFAs than the less extensive respiratory disease. 
The suggested effect of PUFAs in mouse hypersensitivity models can thus be summarized 
as: 
• PUFAs are consumed during the inflammatory reaction, as a suggestion as 
substrates for production of inflammatory mediators. Low levels of PUFAs in 
allergic subjects could thus depend on increased PUFA consumption in these 
subjects, rather than decreased intake, uptake or production from lipid precursors. 
• PUFAs might affect the outcome of the sensitization phase, particularly promoting 
Th2 sensitization. In contrast, PUFA feeding decreased maturation of functional 
Th1 cells. 
• Concerning decreased maturation of Th1 cells, similar effects were seen with 
either fish oil, containing a high proportion of n-3 PUFAs, or sunflower oil, 
containing mainly n-6 PUFAs. 
 
Dietary habits among farmer families could be a protective factor against 
allergy in the farming environment 
A small dairy farm is the most allergy-protective environment observed in economically 
developed countries. The reason for this is not known, but the diet of farmers and their 
children may play a role. Since almost all Swedish infants born today are exclusively 
breast-fed for several months, breast milk is the major dietary factor that could modulate 
allergy development. We investigated breast milk and serum from women on small dairy 
farms and non-farming control mothers living in the same rural area with respect to 
PUFA pattern. We also investigated the diet of the mothers by FFQ and by 24-h recall 
and 24-h dietary record. Fig 9A shows the composite pattern of breast milk PUFA 
composition and maternal diet – breast milk PUFAs are shown in italics. Milk from 
farming women had higher levels of the saturated fatty acids 18:0 and 20:0, while milk  
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from non-farming women had higher levels of the saturated fatty acid 22:0 and the 
PUFAs LA (n-6), LNA (n-3) and DPA (n-3), Fig 9B. Dietary habits among farming 
women also differed significantly in several respects from the habits of non-farming 
women, Fig 9B. Farmers had a higher intake of foods containing saturated fatty acids, 
such as butter, whole milk and whole-fat cream. Butter, in particular, is rich in the fatty 
acid 18:0. In contrast, non-farming women consumed more margarine, which contains 
high levels of PUFAs such as LA (n-6) as well as a substantial amount of LNA (n-3). 
Non-farming women also consumed more low-fat milk and cream. 
 
Fig.9 A. PLS-DA score plot showing the separation between the groups of mother-infant pairs; farmers and 
non-farming controls. B. PLS-DA loading plot displaying the variables that contributed most to the 
separation between farmers and controls. 
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Children born in dairy farming families have a low incidence of allergies. Our results 
suggest that intake of butter, rather than margarine, could be one explanation for the 
allergy-preventive lifestyle at the small family farm. Several studies have shown that 
intake of PUFA-rich margarine is associated with a higher prevalence of allergies, while 
intake of butter is related to a lower incidence of allergies [58-62]. There can only be 
speculation of the possible immunomodulatory mechanisms of SAFAs versus PUFAs. 
However, one explanation could be that SAFAs are relatively inert and are perhaps not 
substantially active in immune reactions. PUFAs are more reactive because of the double 
bonds and their flexibility and folding abilities. They affect gene transcription, membrane 
fluidity and thrombocyte activation and coagulation, which may all affect immune 
responses. PUFAs are also precursors to several inflammatory mediators such as 
prostaglandins, leukotrienes and thromboxanes. 
 
Farmers seem to have more traditional dietary habits than non-farmers when it comes to 
fats and dairy products. It is probably natural for farmers to eat unprocessed products 
from their own production. Even if they do not produce foods such as cream and butter 
themselves, they obviously choose to buy similar natural products. Although the control 
group lived in the same rural areas as the farmers, they were evidently more prone to 
adopt a more “modern” diet regarding margarine and low-fat products. 
It is impossible to draw conclusions in the present study concerning the effect of the 
individual infant´s breast milk PUFA consumption and subsequent allergy development, 
since the clinical data of the children included have not yet been evaluated. 
High margarine intake is associated with allergy 
We compared the consumption of butter versus margarine in the three cohorts 
investigated, Fig 10. 
Among the lactating women in cohort I, we observed a significantly higher butter intake 
in non-allergic women than in women with isolated respiratory allergy. Comparing all 
allergic women (including those with eczema and respiratory allergy) with the non-
allergic group, a significantly higher intake of butter among non-allergic women was 
found, as well as a trend toward higher margarine consumption among allergic women. 
In cohort II, dietary data were available from 13-year-old adolescents. The results for 
butter and margarine consumption did not differ greatly between allergic and non-allergic 
adolescents. However, a tendency toward higher margarine and butter intake was reported 
in the allergic group. 
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As mentioned above, there were obvious differences in butter and margarine consumption 
between farming and non-farming women. Farmers ate significantly more butter and non-
farmers ate more margarine. 
The dietary patterns in all three cohorts (I. Allergic and non-allergic women, II: Allergic 
and non-allergic 13 year olds´ and III. Farming and non-farming women) indicated strong 
associations both between high margarine intake and high incidence of allergy and 
between a high butter intake and a low prevalence of allergy. 
 
 
Fig. 10 Butter and margarine intake according to FFQ in the cohorts investigated in the present thesis; 
Cohort I – Allergic and non-allergic lactating women, Cohort II – Allergic and non-allergic 13-year-old 
adolescents and Cohort III – Farming and non-farming women. Only butter and margarine as bread 
spread was asked for in cohort I, and this does therefore not include use in cooking. 
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CONCLUSIONS 
 
• PUFAs appear to facilitate atopic sensitization and allergy development. This 
is true of n-3 PUFAs, as opposed to the previous models that attribute an 
allergy-preventive effect. Thus, mice fed a diet rich in n-3 PUFA produced 
more IgE than mice fed a regular diet (low in fat). Further, a high 
concentration of PUFAs, both of the n-3 and n-6 series, in the newborn infants 
(umbilical cord blood) was associated with a high risk of allergy development. 
 
 
• PUFAs are consumed in the body during the inflammation reaction. This may 
explain the reduced breast milk and serum levels of PUFAs in allergic 
subjects, despite a similar, or even higher, intake of foods containing PUFAs. 
For example, women with allergy including eczema have lower breast milk 
and serum levels of typical fish PUFAs compared to non-allergic women and 
women with respiratory allergy, despite a high intake of fish. 
 
 
• Women on small dairy farms had a breast milk fatty acid pattern that differed 
from non-farming women in the same rural region, most notably showing 
higher levels of the saturated fatty acid 18:0. Their dietary intake of butter and 
dairy products rich in saturated fat was also high, while controls ingested 
relatively more margarine containing n-6 PUFAs and had higher levels of 
several PUFAs in their breast milk. These differences in diet will, most likely, 
later also be manifest in children growing up on farms and in their non-
farming counterparts. On the basis of our findings of PUFAs as a risk factor 
for sensitization and allergy, we propose that a diet containing less PUFAs 
may be one factor that helps to explain the allergy-preventing effect of 
growing up on a dairy farm. 
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